Table 2 Demographics

N = 166

135

31

Male, a)

54 (40)

15 (48)

0.514

Gestational Age Weeks (wk + d), b)

29 + 2 (± 2 + 2)

27 + 6 (± 2 + 0)

0.001

Birth weight g, b)

1160.56 (± 267.62)

974.97 (± 276.40)

0.001

Umbilical artery pH, b)

7.30 (± 0.09)

7.29 (± 0.08)

0.811

Apgar 1′/5′/10′, c)

7 / 8 / 8

7 / 8 / 8

0.125 / 0.041 / 0.057

Apgar 1′/5′/10′ c)

(1; 6–8; 9 / 3; 7–8; 9 / 5; 8–9 10)

(4; 6–8; 8 / 3; 7–8; 9 / 3; 8–8; 9)

CRIB-Score, c)

1 (0 / 0–3 / 11)

3 (0 / 1.75–5.25 / 12)

0.001

Highest Bilirubin, μmol/l, b)

143.85 (± 23.44)

148.74 (± 62.31)

0.472

Antenatal steroids 1 dose / 2 doses, a)

72 (53) / 35 (26)

18 (58) / 11 (35)

0.633 / 0.284

Ceaseraen delivery, a)

121 (90)

30 (97)

0.366

Patent ductus arteriosus, d)

36 (27)

10 (32)

0.830

BPD, f)

6 (4)

6 (19)

0.011

Retinopathia neonatorum ≥3, d)

2 (1)

0

0.999

Intraventricular haemorrhage ≥3, d)

4 (3)

2 (6)

0.312

Periventricular leukomalacia, d)

1 (1)

1 (3)

0.340

Parental Education Score 1/2 d); 3/4 a); ^a)

1 (1) / 7 (5) / 76 (56) / 47 (35)

0 / 2 (6) / 17 (55) / 10 (32)

0.999 / 0.667 / 0.999 / 0.999

Max CrP 72 h postnatal, c)

0.62 (0 / 0–1.525 / 8.37)

14.36 (5.37 / 9.5–28.07 / 68.45)

0.000

Leukocytes in first CBC, ×10⁹, b)

9.9 (±5.71)

10.22 (±11.09)

0.824

Leukopenia a)

9 (7)

10 (32)

0.000

Leukocytosis d)

4 (3)

3 (10)

0.122

Combinded abnormal WBC a)

13 (10)

13 (42)

0.000

Thrombocytes in first CBC, ×  10⁹, b)

181.8 (±69.7)

173.4 (±71.7)

0.547

Thrombocytopenia, a)

40 (30

14 (45)

0.146

Severe thrombocytopenia, d)

3 (2)

2 (6)

0.234

Last Maternal CrP prior to Birth,c)

7.21 (0 / 2.49–20.41 / 70.77)

8.8 (0 / 2.04–29.16 / 64.93)

0.541

PROM < 24 h / >  24 h />  1 week, d)

36 (27) / 10 (7) / 17 (13)

3 (10) / 0 / 12 (39)

0.059 / 0.211 / 0.001

Chorioamnionitis, d)

8 (6)

6 (19)

0.026

LOS d)

27 (20)

9 (29)

0.211

Age at BSIDII, month, e)

24 (23–30)

25 (24–31)

0.323

Total sepsis symptoms c) ^b

3 (0 / 2–3.5 / 6)

4 (2 / 3–5 / 7)

0.000